PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ... India TV, 2 weeks ago
Cadila Health up 3%, diabetic drug gets tentative USFDA nod - Money Control, 2 weeks ago
Zydus gets USFDA tentative nod for diabetic tablets - Press Trust of India, 2 weeks ago
3 images for "cadila health"
Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...BusinessWeek, 2 weeks ago Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms Business Standard India, 1 week ago Generic drugs help US save $239 bn in healthcare spend in 2013 Livemint.com, 1 week ago Gilead Inks Generic Licensing Pacts to Increase Access to Hepatitis C Treatments in Developing Countries [Health & Beauty Close - Up] Pharmacy Choice, 1 week ago
Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones. Zydus Cadila has received the final approval from the United States Food and Drug Administration ...Business Standard, 1 month ago Zydus Cadila Gets US Regulatory Nod for Kidney Stone Tablets NDTV Profit, 1 month ago Zydus Cadila gets US FDA nod to market kidney stone tablets Livemint.com, 1 month ago Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tablets Economic Times, 1 month ago
Cadila Healthcare Ltd has submitted to BSE a copy of proceedings of the 19th Annual General Meeting of the members of the Company held on July 30, 2014.Source : BSE Read all announcements in Cadila Health To read the full reportMoneycontrol.com, 1 month ago Cadila's Moraiya facility under US FDA lens Business Standard India, 2 months ago USFDA raises a red flag for Cadila's ANDA application Business Standard India, 1 month ago FDA raises concern over drug production process at India's Cadila Reuters, 2 months ago
D On specific stocks, he is betting on pharma stocks and likes Ajanta Pharma , IPCA Labs , Cadila Health , Torrent Pharma and Alembic Pharma . From the FMCG space, he is cautious on cigarette major ITC on the back of tobacco business-related ...Moneycontrol.com, 1 month ago Pharma stocks outperform equity benchmarks, rally 2-14% Moneycontrol.com, 1 month ago Pharmexcil to celebrate 10 years of success on Sept 18 & 19 in Hyderabad PharmaBiz, 2 weeks ago
Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.Money Control, 1 month ago
Vishal Malkan, malkansview.com advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450.Money Control, 2 months ago Buy Hathway Cable, Cadila Health, Wockhardt: AK Prabharkar Money Control, 2 months ago
Summary We remain neutral on Cadila Healthcare (CDH) due to lopsided growth, but revise our target price to R1,180 (earlier R910) as we roll our valuations forward to July 2015. We value Cadila using our standard three-stage DCF model with five-year ...Financial Express, 1 month ago Cadila Health up 2.5%, Credit Suisse maintains outperform Money Control, 2 months ago
Consolidated revenue jumped 25.2 percent to Rs 2,050 crore in the quarter ended June 2014 from Rs 1,637 crore in same quarter last year. "Sales growth was buoyed by formulations business in the US, which grew by 88 percent during the quarter," said the ...Money Control, 2 months ago
Paras Bothra of Ashika Stock Broking recommends buying Berger Paints with a target of Rs 320 and Jyothy Laboratories.Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!